Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Mar-18 5:31 PM View:  | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 152,500 | -- | -- | 37% 414.09K to 566.59K | |
| 16-Feb-18 4:04 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 15,318 | $4.81 | $73,679.60 | (4%) 429.4K to 414.09K | 30% |
| 31-Jan-18 5:19 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 29-Jan-18 | Grant | 4,403 | $4.81 | $21,178.40 | (1%) 433.81K to 429.4K | 30% |
| 08-Jan-18 6:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Jan-18 | Market Sale | 1,067 | $4.69 | $5,004.23 | (< 1%) 368.69K to 367.62K | 28% |
| 31-Jan-18 5:19 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 07-Nov-17 | Grant | 125,000 | -- | -- | 34% 367.62K to 492.62K | |
| 31-Jan-18 5:19 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 07-Nov-17 | Payment of Exercise | 58,813 | $5.15 | $302,887.00 | (12%) 492.62K to 433.81K | 35% |
| 31-Oct-17 4:11 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Oct-17 | Market Sale | 4,055 | $6.03 | $24,451.70 | (1%) 372.74K to 368.69K | 44% |
| 06-Oct-17 5:25 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Oct-17 | Market Sale | 895 | $7.19 | $6,435.05 | (< 1%) 373.64K to 372.74K | 53% |
| 01-Aug-17 4:32 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 31-Jul-17 | Market Sale | 4,131 | $7.14 | $29,495.30 | (1%) 377.77K to 373.64K | 53% |
| 06-Jul-17 6:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Jul-17 | Market Sale | 910 | $7.67 | $6,979.70 | (< 1%) 378.68K to 377.77K | 56% |
| 03-May-17 4:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 01-May-17 | Market Sale | 4,122 | $5.97 | $24,608.30 | (1%) 382.8K to 378.68K | 44% |
| 06-Apr-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Apr-17 | Market Sale | 911 | $5.80 | $5,283.80 | (< 1%) 383.71K to 382.8K | 42% |
| 15-Mar-17 6:26 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 14-Feb-17 | Grant | 150,000 | -- | -- | 64% 233.71K to 383.71K | |
| 13-Feb-17 4:18 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Feb-17 | Market Sale | 1,611 | $5.47 | $8,812.17 | (< 1%) 235.32K to 233.71K | 39% |
| 31-Jan-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jan-17 | Market Sale | 18,248 | $4.65 | $84,853.20 | (7%) 253.57K to 235.32K | 28% |
| 06-Jan-17 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Jan-17 | Market Sale | 1,077 | $6.16 | $6,634.32 | (< 1%) 254.65K to 253.57K | 45% |
| 14-Nov-16 4:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Nov-16 | Market Sale | 1,559 | $4.99 | $7,779.41 | (< 1%) 256.21K to 254.65K | 33% |
| 06-Oct-16 4:05 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Oct-16 | Market Sale | 917 | $5.38 | $4,933.46 | (< 1%) 257.12K to 256.21K | 38% |
| 11-Aug-16 5:44 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Aug-16 | Market Sale | 1,622 | $4.22 | $6,844.84 | (< 1%) 258.75K to 257.12K | 20% |
| 11-Aug-16 5:45 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Aug-16 | Market Sale Duplicate | 1,622 | $4.22 | $6,844.84 | (< 1%) 258.75K to 257.12K | 20% |
| 06-Jul-16 4:17 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Jul-16 | Market Sale | 936 | $6.66 | $6,233.76 | (< 1%) 259.68K to 258.75K | 50% |
| 10-May-16 4:35 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-May-16 | Market Sale | 1,873 | $5.42 | $10,151.70 | (< 1%) 261.55K to 259.68K | 38% |
| 07-Apr-16 5:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Apr-16 | Market Sale | 1,078 | $4.50 | $4,851.00 | (< 1%) 262.63K to 261.55K | 25% |
| 10-Feb-16 10:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Feb-16 | Market Sale | 1,938 | $3.23 | $6,259.74 | (< 1%) 264.57K to 262.63K | (4%) |
| 01-Feb-16 6:57 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 28-Jan-16 | Grant | 153,750 | -- | -- | 139% 110.82K to 264.57K | |
| 06-Jan-16 9:43 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 06-Jan-16 | Market Sale | 4,261 | $4.83 | $20,580.60 | (4%) 115.08K to 110.82K | 30% |
| 12-Nov-15 5:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Nov-15 | Market Sale | 1,638 | $5.18 | $8,484.84 | (1%) 116.72K to 115.08K | 35% |
| 24-Aug-15 6:10 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 20-Aug-15 | Market Purchase | 9,984 | $5.68 | $56,759.00 | 9% 106.73K to 116.72K | (41%) |
| 12-Aug-15 7:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 10-Aug-15 | Market Sale | 1,683 | $6.07 | $10,215.80 | (2%) 108.42K to 106.73K | 45% |
| 12-May-15 7:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 08-May-15 | Payment of Exercise | 1,625 | $9.32 | $15,145.00 | (1%) 110.04K to 108.42K | 64% |
| 10-Mar-15 5:31 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 06-Mar-15 | Market Purchase | 6,380 | $12.53 | $79,941.40 | (5%) 116.42K to 110.04K | 73% |
| 10-Feb-15 9:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Feb-15 | Market Sale | 6,759 | $10.95 | $74,011.00 | (6%) 110.42K to 103.66K | 69% |
| 06-Jan-15 8:46 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 04-Jan-15 | Grant | 33,875 | -- | -- | 44% 76.55K to 110.42K | |
| 04-Mar-13 4:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 28-Feb-13 | Grant | 18,800 | -- | -- | 100% 0 to 18.8K |